SCHEMBL17489250

SCHEMBL17489250

Cc1nc2c(F)cc(-c3nc(Nc4ccc(N5C[C@@H]6NCCO[C@H]6C5)cn4)ncc3F)cc2n1C(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 19/20 0.56
CDK6 Q00534 16/20 0.56
CDK1 P06493 12/20 0.56
CDK2 P24941 9/20 0.56
CDK7 P50613 5/20 0.56
CDK9 P50750 5/20 0.56
CCND3 P30281 10/20 0.55
CCNA2 P20248 8/20 0.55
CDK5 Q00535 3/20 0.55
EGFR P00533 2/20 0.55
CCNB1 P14635 2/20 0.55
CCNE1 P24864 2/20 0.55
CIT O14578 1/20 0.55
GAK O14976 1/20 0.55
DYRK3 O43781 1/20 0.55
CCNT1 O60563 1/20 0.55
STK16 O75716 1/20 0.55
CCNK O75909 1/20 0.55
STK10 O94804 1/20 0.55
PRKD3 O94806 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17489249 1.00 CDK4 (0.56) CDK4CDK6CDK1CDK2CDK7
SCHEMBL17489173 0.93 CDK4 (0.61) CDK4CDK6CDK1CDK2CDK7
SCHEMBL17489253 0.87 CDK4 (0.68) CDK4CDK6CDK1CDK2CDK7
SCHEMBL17488758 0.87 CDK4 (0.68) CDK4CDK6CDK1CDK2CDK7
SCHEMBL17489288 0.86 CDK4 (0.53) CDK4CDK6CDK1CDK2CDK7
SCHEMBL17488855 0.85 CDK4 (0.70) CDK4CDK6CDK1CDK2CDK7
SCHEMBL17488811 0.85 CDK4 (0.70) CDK4CDK6CDK1CDK2CDK7
SCHEMBL17489287 0.85 CDK4 (0.68) CDK4CDK6CDK1CDK2CDK7
SCHEMBL17489233 0.85 CDK4 (0.64) CDK4CDK6CDK1CDK2CDK7
SCHEMBL17488767 0.85 CDK4 (0.64) CDK4CDK6CDK1CDK2CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016015605-A1 COMPOUNDS AS CDK SMALL-MOLECULE INHIBITORS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-02-04 WO disclosed